Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Waldenstrom Macroglobulinemia × Neoadjuvant Therapy × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 85 Rectal Neoplasms 43 Colorectal Neoplasms 43 Carcinoma, Non-Small-Cell Lung 29 Esophageal Neoplasms 23 Esophageal Squamous Cell Carcinoma 21 Lung Neoplasms 20 Stomach Neoplasms 18 Pancreatic Neoplasms 18 Neoplasms 15 Colonic Neoplasms 14 Carcinoma, Hepatocellular 14 Neoplasm Metastasis 13 Squamous Cell Carcinoma of Head and Neck 12 Prostatic Neoplasms 12 Ovarian Neoplasms 12 Adenocarcinoma Of Esophagus 12 Head and Neck Neoplasms 11 Urinary Bladder Neoplasms 10 Sarcoma 10 Uterine Cervical Neoplasms 9 Osteosarcoma 8 Fallopian Tube Neoplasms 8 Inflammatory Breast Neoplasms 7 Central Nervous System Neoplasms 7 Carcinoma, Intraductal, Noninfiltrating 7 Multiple Myeloma 6 Liver Neoplasms 6 Kidney Neoplasms 6 Carcinoma, Ovarian Epithelial 6

Interventions

Rituximab 93 Cyclophosphamide 53 fludarabine phosphate 45 Peripheral Blood Stem Cell Transplantation 41 Bortezomib 31 Mycophenolic Acid 30 Whole-Body Irradiation 29 ibrutinib 28 Dexamethasone 27 Cyclosporine 21 Tacrolimus 20 Etoposide 19 zanubrutinib 18 Filgrastim 18 Melphalan 17 Lenalidomide 17 Busulfan 17 Radiotherapy 16 Methotrexate 14 Antilymphocyte Serum 14 Bendamustine Hydrochloride 13 Sirolimus 11 Calcium Dobesilate 11 Everolimus 9 venetoclax 8 ibritumomab tiuxetan 8 Prednisone 8 Indium 8 Cytarabine 8 Cyclosporins 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07259122 2025-12-02

ZBR in WM

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Not yet recruiting

Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡